| 000 | 01680nam a2200433 i 4500 | ||
|---|---|---|---|
| 999 |
_c272673 _d272673 |
||
| 001 | on1041110256 | ||
| 003 | OCoLC | ||
| 005 | 20180731131811.0 | ||
| 006 | m o d f | ||
| 007 | cr mn||||||||| | ||
| 008 | 180619s2018 dcuab o f000 0 eng c | ||
| 040 |
_aPUCPR _beng _erda _epn _cGPO _dMvI |
||
| 042 | _apcc | ||
| 043 | _an-us--- | ||
| 074 | _a0967-L-02 (online) | ||
| 086 | 0 | _aJ 24.32:F 36 | |
| 099 | _aJ 24.32:F 36 | ||
| 245 | 0 | 0 | _aFentanyl remains the most significant synthetic opioid threat and poses the greatest threat to the opioid user market in the United States. |
| 264 | 1 |
_a[Washington, D.C.] : _bDEA Strategic Intelligence Section, _c2018. |
|
| 300 |
_a1 online resource (11 pages) : _bcolor illustrations, color maps. |
||
| 336 | _btxt | ||
| 337 |
_bc _2rdamedia |
||
| 338 |
_bcr _2rdacarrier |
||
| 490 | 1 | _aDEA intelligence brief | |
| 500 | _a"This product was prepared by the DEA Strategic Intelligence Section"--Page 11. | ||
| 500 | _a"May 2018." | ||
| 500 | _a"DEA-DCT-DIB-003-18." | ||
| 500 | _a"Unclassified." | ||
| 500 | _aCRDP Program record. | ||
| 588 | _aDescription based on online resource; title from PDF title page (Drug Enforcement Administration website, viewed June 19, 2018). | ||
| 710 | 1 |
_aUnited States. _bDrug Enforcement Administration. _bStrategic Intelligence Section, |
|
| 830 | 0 | _aDEA intelligence brief. | |
| 856 | 4 | 0 | _uhttps://purl.fdlp.gov/GPO/gpo93751 |
| 650 | 0 |
_aFentanyl _zUnited States. |
|
| 650 | 0 |
_aFentanyl _xOverdose _zUnited States. |
|
| 650 | 0 |
_aSynthetic drugs _zUnited States. |
|
| 650 | 0 |
_aOpioid abuse _zUnited States. |
|
| 942 |
_2sudocs _c8 |
||